Form 4 Filing for Kymera Therapeutics, Inc. - Elena Ridloff

Elena Ridloff, a director at Kymera Therapeutics, Inc. (KYMR), acquired 6,068 stock options on June 24, 2026. These options, which allow for the purchase of common stock, have an exercise price of $99.87 and expire on June 23, 2036. The options vest in full on the earlier of June 24, 2027, or the date of the company's next annual stockholder meeting. The transaction was reported on Form 4, with the signature dated June 25, 2026.